Candriam SCA’s Tenet Healthcare THC Stock Holding History

Candriam SCA’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.07M	Sell	16,439 -185,719	-92%	-$34.1M	0.01%	455
2026 Q1	$38.1M	Buy	202,158 +23,557	+13%	+$4.96M	0.2%	112
2025 Q4	$35.5M	Buy	178,601 +143,785	+413%	+$29.1M	0.18%	128
2025 Q3	$7.07M	Buy	34,816 +10,310	+42%	+$1.83M	0.04%	316
2025 Q2	$4.31M	Buy	+24,506	New	+$3.69M	0.02%	377
2025 Q1	–	Sell	-142,001	Closed	-$17.9M	–	711
2024 Q4	$17.9M	Buy	142,001 +52,491	+59%	+$7.8M	0.1%	181
2024 Q3	$14.9M	Buy	+89,510	New	+$13.5M	0.09%	216
2018 Q3	–	Sell	-20,000	Closed	-$671K	–	841
2018 Q2	$671K	Buy	+20,000	New	+$622K	0.01%	667
2016 Q2	–	Sell	-102,559	Closed	-$2.95M	–	676
2016 Q1	$2.95M	Buy	+102,559	New	+$2.67M	0.07%	270

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Candriam SCA's THC Position: Q2 2026 in Review

Candriam SCA reduced its Tenet Healthcare (THC) stake by 92% in Q2 2026, selling an estimated $34.1M and leaving 16,439 shares worth $3.07M. The position accounts for 0.01% of the portfolio, ranked #455.

Candriam SCA first reported a position in THC in Q1 2016 and has held it in 9 quarters since. The position peaked at $38.1M in Q1 2026. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

Candriam SCA held 16,439 shares of Tenet Healthcare worth $3.07M as of Q2 2026.
Candriam SCA sold 185,719 Tenet Healthcare shares in Q2 2026, an estimated $34.1M.
Tenet Healthcare made up 0.01% of Candriam SCA's portfolio in Q2 2026, its #455 holding.
Candriam SCA first reported a position in Tenet Healthcare in Q1 2016 and has held it in 9 quarters since.
Candriam SCA's Tenet Healthcare position peaked at $38.1M in Q1 2026.
678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.